Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When is retransplantation a viable option?

Maryl R Johnson1

  • 1University of Wisconsin Hospital and Clinics, Madison, WI 53792, USA. mrj@medicine.wisc.edu

Heart Failure Clinics
|June 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nocturnal Oxygen Therapy for Central Sleep Apnea in Patients with Heart Failure: A Multisite, Double-Blind, Sham-controlled Randomized Clinical Trial (LOFT-HF).

Annals of the American Thoracic Society·2025
Same author

Heart Transplant Performance Metrics: Separating Signal From Noise.

JACC. Heart failure·2024
Same author

But Is All Post-Transplant Lymphoproliferative Disorder Created Equal?

JACC. Heart failure·2024
Same author

Heart Transplantation-Postoperative Considerations.

Critical care clinics·2023
Same author

Simultaneous heart-kidney transplant: Working together to define when one organ is not enough.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2021
Same author

Heart and kidney transplant: should they be combined or subsequent?

ESC heart failure·2020
Same journal

Pulmonary Vascular Disease Across the Continuum: From Mechanisms to Precision Care.

Heart failure clinics·2026
Same journal

Long-term Complications of Pulmonary Embolism: Which Is the Optimal Follow-Up?

Heart failure clinics·2026
Same journal

Recent Advances in Pulmonary Hypertension Management.

Heart failure clinics·2026
Same journal

The Role of Machine Learning and Artificial Intelligence in Drug Discovery and Clinical Care of Pulmonary Hypertension.

Heart failure clinics·2026
Same journal

Portopulmonary Hypertension: Current Perspectives.

Heart failure clinics·2026
Same journal

Exercise Training and Cardiac Rehabilitation in Chronic Thromboembolic Pulmonary Hypertension.

Heart failure clinics·2026
See all related articles

Heart transplant recipients face risks of cardiac allograft vasculopathy and dysfunction, potentially requiring retransplantation. Careful patient selection is crucial due to donor shortages and compromised outcomes in repeat heart transplantation.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Increasing heart transplant recipient survival leads to higher risk of cardiac allograft vasculopathy (CAV) and dysfunction.
  • These complications may necessitate consideration for heart retransplantation.
  • Outcomes after cardiac retransplantation are generally poorer than primary transplantation.

Purpose of the Study:

  • To define criteria for judicious candidate selection for heart retransplantation.
  • To outline appropriate timing and clinical scenarios for considering retransplantation.
  • To highlight factors requiring thorough assessment in potential retransplant candidates.

Main Methods:

  • Review of clinical outcomes and indications for heart retransplantation.

Related Experiment Videos

  • Analysis of patient factors influencing retransplantation success.
  • Identification of contraindications and risk factors.

    • Main Results:

    • Heart retransplantation is most appropriate for patients >6 months post-transplant with severe CAV and left ventricular dysfunction.
    • Alternatively, patients with allograft dysfunction and progressive heart failure without acute rejection are candidates.
    • Relative contraindications like advanced age, comorbidities, and psychosocial issues need careful evaluation.

    Conclusions:

    • Judicious selection of heart transplant candidates for retransplantation is essential due to donor scarcity and compromised outcomes.
    • Specific clinical criteria, including timing and absence of acute rejection, guide retransplantation decisions.
    • Comprehensive assessment of potential contraindications is vital for optimizing retransplant outcomes.